NeoStem Inc. is engaged in a platform business of operating a commercial autologous adult stem cell bank and is pioneering the pre-disease collection processing and long-term storage of stem cells from adult donors.


Updates from The Motley Fool

Latest updates on Neostem from Fool.com.


Stock Performance

View Interactive CLBS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Neostem.
Current Price: $4.87
Prev Close: $5.16
Open: $5.22
Bid: $4.80
Ask: $5.23
Day's Range: $4.80 - $5.22
52wk Range: $2.65 - $8.68
Volume: 77,561
Avg Vol 191,095
Market Cap: $40M
P/E (ttm): -1.03
EPS (ttm): ($4.99)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Neostem.
CAPS Rating 1 out of 5
 
171 Outperform
17 Underperform
CAPS All Stars
 
14 Outperform
9 Underperform

How do you think Neostem will perform against the market?



You pick for Neostem is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

David J. Mazzo, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Neostem.

NeoStem Inc. is engaged in a platform business of operating a commercial autologous adult stem cell bank and is pioneering the pre-disease collection processing and long-term storage of stem cells from adult donors.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT